Guardant Health, Inc. (GH): Price and Financial Metrics
GH Price/Volume Stats
| Current price | $47.89 | 52-week high | $52.92 |
| Prev. close | $48.41 | 52-week low | $20.14 |
| Day low | $47.43 | Volume | 1,588,856 |
| Day high | $50.25 | Avg. volume | 2,346,422 |
| 50-day MA | $43.06 | Dividend yield | N/A |
| 200-day MA | $35.71 | Market Cap | 5.93B |
GH Stock Price Chart Interactive Chart >
Guardant Health, Inc. (GH) Company Bio
Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.
GH Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
GH Price Returns
| 1-mo | 20.51% |
| 3-mo | 21.80% |
| 6-mo | 29.89% |
| 1-year | 65.02% |
| 3-year | 18.69% |
| 5-year | -42.45% |
| YTD | 56.76% |
| 2024 | 12.94% |
| 2023 | -0.55% |
| 2022 | -72.81% |
| 2021 | -22.39% |
| 2020 | 64.93% |